Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

2019525 citationsJournal Articlegreen Open Access

Authors

ClinicalTrials.gov identifier: NCT02774187.

Good health and well-being

Published in: JAMA Oncology

Volume 5, Issue 7, pp. 953-953

Field-Weighted Citation Impact: 25.98